KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $8.9 billion.

  • Quest Diagnostics' Total Liabilities fell 380.38% to $8.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 billion, marking a year-over-year decrease of 380.38%. This contributed to the annual value of $9.3 billion for FY2024, which is 2161.46% up from last year.
  • Per Quest Diagnostics' latest filing, its Total Liabilities stood at $8.9 billion for Q3 2025, which was down 380.38% from $8.7 billion recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Total Liabilities registered a high of $9.3 billion during Q4 2024, and its lowest value of $6.7 billion during Q1 2023.
  • Moreover, its 5-year median value for Total Liabilities was $7.1 billion (2021), whereas its average is $7.6 billion.
  • As far as peak fluctuations go, Quest Diagnostics' Total Liabilities plummeted by 723.66% in 2021, and later skyrocketed by 3184.21% in 2024.
  • Quarter analysis of 5 years shows Quest Diagnostics' Total Liabilities stood at $7.1 billion in 2021, then fell by 3.1% to $6.9 billion in 2022, then grew by 11.19% to $7.7 billion in 2023, then grew by 21.61% to $9.3 billion in 2024, then dropped by 4.69% to $8.9 billion in 2025.
  • Its last three reported values are $8.9 billion in Q3 2025, $8.7 billion for Q2 2025, and $8.8 billion during Q1 2025.